Diagnosis and Monitoring of Disease Progression Using Deep Neuro Signatures

Active, not recruitingOBSERVATIONAL
Enrollment

3,500

Participants

Timeline

Start Date

January 31, 2022

Primary Completion Date

January 31, 2029

Study Completion Date

January 31, 2030

Conditions
Alzheimer's DiseaseMild Cognitive Impairment
Trial Locations (1)

Unknown

Nikaia Ag Panteleimon Hospital, Athens

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Eisai Co., Ltd.

INDUSTRY

collaborator

Ionian University

OTHER

lead

Altoida

INDUSTRY

NCT05153941 - Diagnosis and Monitoring of Disease Progression Using Deep Neuro Signatures | Biotech Hunter | Biotech Hunter